The largest study to examine outcomes for patients treated outside a clinical trial setting with a minimally invasive procedure to repair a poorly functioning mitral valve in the heart found that the ...

Progress continues to be made on new transcatheter devices for the treatment of severe mitral and tricuspid regurgitation, investigators reported. Several valve repair and replacement technologies, ...

Data from a 5-year follow-up of outcomes after transcatheter edge-to-edge repair of severe mitral regurgitation, as compared with outcomes after maximal doses of guideline-directed medical therapy ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window PHOENIX -- ...

With a green light from the FDA, Abbott is scaling up its replacement mitral and aortic valve portfolio to epic proportions—or, more specifically, to Epic Plus proportions. The upgraded edition of the ...

Additionally, several new trials reporting longer-term follow-up on MICS coronary and valve surgery have demonstrated durable ...

Patients who underwent mitral valve replacement had a more than threefold higher 10-year rate of infective endocarditis than those at moderate risk for the disease, whereas undergoing mitral valve ...

Please provide your email address to receive an email when new articles are posted on . In patients who had mitral valve surgery but also tricuspid regurgitation or tricuspid annular dilation, ...

Doctors classify mitral valve regurgitation into four progressive stages. Symptoms typically don’t appear until the final stages but monitoring and treatment in earlier stages may help slow ...